Megapolitan Developments Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Megapolitan Developments Tbk. trades at Rp70 (market cap 234.5B, 4.72M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp250 (market cap 167.37B, 40.6K 24h volume). The key difference: Megapolitan Developments Tbk. is the larger of the two by market cap, and Megapolitan Developments Tbk. is more actively traded (4.72M versus 40.6K). Which is the better fit depends on your goals.
| EMDE | OBAT | |
|---|---|---|
Market Cap | 234.5B | 167.37B |
Volume | 4.72M | 40.6K |
Lot | 47.16K | 406 |
Turnover | 330.43M | 10.01M |
Average Price | 70.07 | 246.6 |
Value | 330.43M | 10.01M |
Indicative Equilibrium Price | 70 | 246 |
Indicative Equilibrium Volume | 30.1K | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Megapolitan Developments (formerly Megapolitan Developments Corporation) (the Company) was established based on Notary Deed No. 24 dated September 10, 1976 by Soeleman Ardjasasmita, S.H., Notary in Jakarta.
Read more on EMDE →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →